文献速递脊柱脊髓外科

老年退变性腰骶椎择期手术中抗凝与抗血小板治疗的管理:578例老年患者的临床研究

Management of Anticoagulant and Antiplatelet Therapy in Elective Degenerative Lumbosacral Spine Surgery: A Clinical Study on 578 Elderly Patients.
PubMed 文献 · Neurosurgery · 2025-05-09

回顾性分析578例60岁及以上因腰椎管狭窄、腰椎间盘突出或滑脱行择期手术的患者,按抗血栓方案分为无治疗组(A组)、一级预防组(B组)和二级预防组(C组),围术期必要时采用依诺肝素或低剂量阿司匹林桥接。结果显示各组术中失血量和手术时间无显著差异,B组腰椎管狭窄患者住院时间较A组短(P=0.01),C组椎间盘突出患者住院时间较A组短(P<0.01),并发症以Clavien-Dindo I或II级为主,无大出血或心血管事件记录。作者认为个体化围术期抗血栓管理可行,需进一步前瞻性研究完善策略。

要点

  • 578例60岁及以上患者按抗血栓方案分为无治疗、一级预防和二级预防三组。
  • 各组术中失血量和手术时间无显著差异,并发症以Clavien-Dindo I或II级为主。
  • B组腰椎管狭窄患者住院时间较A组短(P=0.01),C组椎间盘突出患者较A组短(P<0.01)。

核心结论

  • 个体化围术期抗血栓治疗管理在高危择期退变性脊柱手术患者中具有可行性。
  • 研究结果支持制定标准化管理策略以优化手术结局而不损害患者安全。
  • 需要进一步前瞻性研究来完善这些策略。

研究设计与样本

  • 回顾性分析578例60岁及以上因腰椎管狭窄、腰椎间盘突出或滑脱行择期手术的患者。
  • 按抗血栓方案分为无治疗组(A组)、一级预防组(B组)和二级预防组(C组)。
  • 围术期必要时采用依诺肝素或低剂量阿司匹林桥接。

主要发现

  • 各组术中失血量和手术时间无显著差异。
  • B组腰椎管狭窄患者住院时间较A组短(P=0.01)。
  • C组椎间盘突出患者住院时间较A组短(P<0.01)。
  • 并发症以Clavien-Dindo I或II级为主,无大出血或心血管事件记录。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Managing anticoagulant and antiplatelet therapy in elderly patients with high cardiovascular risk undergoing degenerative lumbosacral spine surgery is a complex challenge. Balancing the reduction of thromboembolic events and minimizing bleeding risks requires tailored perioperative strategies. This study evaluates the outcomes of a standardized management approach for such therapies in this vulnerable population. METHODS: A retrospective analysis was conducted on 578 patients aged 60 years or older undergoing elective surgery for lumbar spinal stenosis, lumbar disc herniation, or spondylolisthesis. Patients were categorized into three groups based on their antithrombotic regimen: no therapy (Group A), primary prevention therapy (Group B), and secondary prevention therapy (Group C). Perioperative bridging with enoxaparin or low-dose aspirin was applied where indicated. Clinical outcomes, including surgical duration, blood loss, postoperative complications (Clavien-Dindo scale), and hospitalization length, were assessed. RESULTS: No significant differences were observed in intraoperative blood loss or surgical duration across groups. Hospitalization duration was shorter in Group B compared with Group A for lumbar stenosis ( P = .01) and in Group C compared with Group A for disc herniation ( P < .01). Complications were predominantly Grade I or II, with no major bleeding or cardiovascular events recorded. The management demonstrated safety and efficacy in maintaining cardiovascular protection while controlling bleeding risks. CONCLUSION: This study highlights the feasibility of individualized perioperative management of antithrombotic therapy in high-risk patients undergoing elective degenerative spine surgery. The findings support the development of standardized management strategies to optimize surgical outcomes without compromising patient safety. Further prospective studies are needed to refine these strategies.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Corazzelli G, De Los Rios D, Gentile D, et al. Management of Anticoagulant and Antiplatelet Therapy in Elective Degenerative Lumbosacral Spine Surgery: A Clinical Study on 578 Elderly Patients. Neurosurgery. 2025. PMID: 40341075. doi:10.1227/neu.0000000000003494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。